People: Columbia University Chemist Is Awarded Swiss Chemical Society's Paracelsus Prize

Ronald Breslow, Samuel Latham Mitchill Professor of Chemistry at Columbia University, has been awarded the Swiss Chemical Society's 1990 Paracelsus Prize, named in honor of the 16th-century Swiss chemist, surgeon, and philosopher. The prize, first awarded in 1941, is given biannually by the Basel, Switzerland-based society and honors leading scientists in the field of chemistry. Accompanying the prize is an award of 20,000 Swiss francs ($12,000). Breslow, 59, was cited for his contributions t

Written byColby Stong
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Ronald Breslow, Samuel Latham Mitchill Professor of Chemistry at Columbia University, has been awarded the Swiss Chemical Society's 1990 Paracelsus Prize, named in honor of the 16th-century Swiss chemist, surgeon, and philosopher.

The prize, first awarded in 1941, is given biannually by the Basel, Switzerland-based society and honors leading scientists in the field of chemistry. Accompanying the prize is an award of 20,000 Swiss francs ($12,000).

Breslow, 59, was cited for his contributions to bioorganic and synthetic organic chemistry. He is only the third scientist from the United States to win the Paracelsus Prize (along with Harvard University chemists E.J. Corey and Frank Westheimer).

In the mid-1960s, Breslow coined the phrase "biomimetic chemistry" to describe a discipline in which scientists create new molecules that imitate some of the most important features of natural enzymes, the catalysts that regulate many vital chemical reactions in the body. In particular, his research has ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies